Correlation coefficients | Gender comparisons | Patients with family cancer history vs. those without family cancer history | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | 2 | 3 | 4 | 5 | 6 | Women M (SD) | Men M (SD) | F | p | d (95% CI) | With M (SD) | Without M (SD) | F | p | d (95% CI) | |
1 | QOL-lung cancer symptoms T1 | .71*** | .66*** | −.11 | −.17† | −.39*** | 32.33 (20.73) | 26.39 (19.19) | 2.41 | .124 | 0.30 (−3.58, 4.17) | 33.79 (21.24) | 23.73 (17.49) | 6.58 | .012 | 0.52 (−3.31, 4.35) |
2 | QOL-lung cancer symptoms T2 | .63*** | −.11 | −.30** | −.36*** | 16.33 (14.69) | 12.45 (9.65) | 2.50 | .117 | 0.32 (−2.10, 2.73) | 16.51 (14.21) | 11.78 (9.69) | 3.68 | .058 | 0.39 (−2.03, 2.80) | |
3 | QOL-lung cancer symptoms T3 | −.05 | −.30** | −.51*** | 18.88 (22.58) | 9.64 (11.87) | 6.32 | .014 | 0.52 (−2.98, 4.02) | 18.08 (22.64) | 9.90 (10.78) | 5.01 | .027 | 0.45 (−3.10, 4.01) | ||
4 | Self-efficacy for managing illness T1 | .63*** | .29** | 3.64 (0.59) | 4.06 (0.49) | 14.56 | >.001 | −0.78 (−0.89, −0.68) | 3.75 (0.61) | 3.98 (0.53) | 4.01 | .048 | −0.40 (−0.52, −0.29) | |||
5 | Self-efficacy for managing illness T2 | .59*** | 4.38 (0.44) | 4.67 (0.29) | 15.18 | >.001 | −0.79 (−0.86, −0.71) | 4.49 (0.43) | 4.57 (0.37) | 1.05 | .308 | −0.20 (−0.28, −0.12) | ||||
6 | Self-efficacy for managing illness T3 | 4.57 (0.36) | 4.77 (0.29) | 9.07 | .003 | −0.62 (−0.68, −0.56) | 4.61 (0.37) | 4.75 (0.30) | 4.23 | .042 | −0.42 (−0.48, −0.35) |